The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease of unknown cause characterized by relentless scarring of the lung parenchyma leading to reduced quality of life and earlier mortality. IPF is an age-related disorder, and with the population aging worldwide, the economic burden of IPF is expected to steadily increase in the future. The mechanisms of fibrosis in IPF remain elusive, with favored concepts of disease pathogenesis involving recurrent microinjuries to a genetically predisposed alveolar epithelium, followed by an aberrant reparative response characterized by excessive collagen deposition. Pirfenidone and nintedanib are approved for treatment of IPF based on their ability to slow functional decline and disease progression; however, they do not offer a cure and are associated with tolerability issues. In this review, we critically discuss how cutting-edge research in disease pathogenesis may translate into identification of new therapeutic targets, thus facilitate drug discovery. There is a growing portfolio of treatment options for IPF. However, targeting the multitude of profibrotic cytokines and growth factors involved in disease pathogenesis may require a combination of therapeutic strategies with different mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Self-citationA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells
Klein, A. M., Mazutis, L., Akartuna, I., Tallapragada, N., Veres, A., Li, V., Peshkin, L., Weitz, D. A., & Kirschner, M. W. (2015) · Cell · doi:10.1016/j.cell.2015.04.044 · Cited by 3,356
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Self-citationRaghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Adams, T. S., Schupp, J. C., Poli, S., Ayaub, E. A., Neumark, N., Ahangari, F., Chu, S. G., Raby, B. A., DeIuliis, G., Januszyk, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1983 · Cited by 1,420
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Habermann, A. C., Gutierrez, A. J., Bui, L. T., Yahn, S. L., Winters, N. I., Calvi, C. L., Peter, L., Chung, M.-I., Taylor, C. J., Jetter, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1972 · Cited by 1,129
Self-citationMode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Pirfenidone in idiopathic pulmonary fibrosis
Taniguchi, H., Ebina, M., Kondoh, Y., Ogura, T., Azuma, A., Suga, M., Taguchi, Y., Takahashi, H., Nakata, K., Sato, A., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00005209 · Cited by 946
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
An overview of the c-MET signaling pathway
Organ, S. L., & Tsao, M.-S. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011422556 · Cited by 875
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Morse, C., Tabib, T., Sembrat, J., Buschur, K. L., Bittar, H. T., Valenzi, E., Jiang, Y., Kass, D. J., Gibson, K., Chen, W., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02441-2018 · Cited by 822
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Self-citationPirfenidone in idiopathic pulmonary fibrosis: Figure 1–
Swigris, J., & Fairclough, D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00071710 · Cited by 799
Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells
Nabhan, A. N., Brownfield, D. G., Harbury, P. B., Krasnow, M. A., & Desai, T. J. (2018) · Science · doi:10.1126/science.aam6603 · Cited by 755
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor
Zacharias, W. J., Frank, D. B., Zepp, J. A., Morley, M. P., Alkhaleel, F. A., Kong, J., Zhou, S., Cantu, E., & Morrisey, E. E. (2018) · Nature · doi:10.1038/nature25786 · Cited by 737
Acellular Normal and Fibrotic Human Lung Matrices as a Culture System for In Vitro Investigation
Booth, A. J., Hadley, R., Cornett, A. M., Dreffs, A. A., Matthes, S. A., Tsui, J. L., Weiss, K., Horowitz, J. C., Fiore, V. F., Barker, T. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0754oc · Cited by 665
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Thomas, A. Q., Lane, K., Phillips, J., Prince, M., Markin, C., Speer, M., Schwartz, D. A., Gaddipati, R., Marney, A., Johnson, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200112-123oc · Cited by 641
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627
Self-citationNoth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614
Xu, Y., Mizuno, T., Sridharan, A., Du, Y., Guo, M., Tang, J., Wikenheiser-Brokamp, K. A., Perl, A.-K. T., Funari, V. A., Gokey, J. J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90558 · Cited by 580
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0541oc · Cited by 567
Self-citationMetformin reverses established lung fibrosis in a bleomycin model
Rangarajan, S., Bone, N. B., Zmijewska, A. A., Jiang, S., Park, D. W., Bernard, K., Locy, M. L., Ravi, S., Deshane, J., Mannon, R. B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0087-6 · Cited by 560
Kobayashi, Y., Tata, A., Konkimalla, A., Katsura, H., Lee, R. F., Ou, J., Banovich, N. E., Kropski, J. A., & Tata, P. R. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0542-8 · Cited by 559
Self-citationFibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G., Mulay, A., Soukiasian, H. J., David, G., Weigt, S. S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1274oc · Cited by 520
Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis
Korfei, M., Ruppert, C., Mahavadi, P., Henneke, I., Markart, P., Koch, M., Lang, G., Fink, L., Bohle, R.-M., Seeger, W., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-313oc · Cited by 514
Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer
Wang, Y., Kuan, P. J., Xing, C., Cronkhite, J. T., Torres, F., Rosenblatt, R. L., DiMaio, J. M., Kinch, L. N., Grishin, N. V., & Garcia, C. K. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.010 · Cited by 496
The rising incidence of idiopathic pulmonary fibrosis in the UK
Navaratnam, V., Fleming, K. M., West, J., Smith, C. J. P., Jenkins, R. G., Fogarty, A., & Hubbard, R. B. (2011) · Thorax · doi:10.1136/thx.2010.148031 · Cited by 484
Stuart, B. D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., Dharwadkar, P., Torres, F., Girod, C. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3278 · Cited by 469
Peljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S.-F., Garcia, J. G. N., Richards, T. J., Silveira, L. J., Lindell, K. O., Steele, M. P., Loyd, J. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.5827 · Cited by 453
Lawson, W. E., Crossno, P. F., Polosukhin, V. V., Roldan, J., Cheng, D.-S., Lane, K. B., Blackwell, T. R., Xu, C., Markin, C., Ware, L. B., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00382.2007 · Cited by 429
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells
Wu, H., Yu, Y., Huang, H., Hu, Y., Fu, S., Wang, Z., Shi, M., Zhao, X., Yuan, J., Li, J., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.027 · Cited by 417
Han, M. K., Zhou, Y., Murray, S., Tayob, N., Noth, I., Lama, V. N., Moore, B. B., White, E. S., Flaherty, K. R., Huffnagle, G. B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70069-4 · Cited by 411
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
Newton, C. A., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C. S., Aravena, C., Meyer, K., Raghu, G., Collard, H. R., & Garcia, C. K. (2016) · European Respiratory Journal · doi:10.1183/13993003.00308-2016 · Cited by 400
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
O’Dwyer, D. N., Ashley, S. L., Gurczynski, S. J., Xia, M., Wilke, C., Falkowski, N. R., Norman, K. C., Arnold, K. B., Huffnagle, G. B., Salisbury, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1650oc · Cited by 366
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs
Lawson, W. E., Cheng, D.-S., Degryse, A. L., Tanjore, H., Polosukhin, V. V., Xu, X. C., Newcomb, D. C., Jones, B. R., Roldan, J., Lane, K. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107559108 · Cited by 363
Iyer, S. N., Gurujeyalakshmi, G., & Giri, S. N. (1999) · PubMed · Cited by 358
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
Moodley, Y., Atienza, D., Manuelpillai, U., Samuel, C. S., Tchongue, J., Ilancheran, S., Boyd, R., & Trounson, A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080629 · Cited by 356
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
Yu, G., Tzouvelekis, A., Wang, R., Herazo-Maya, J. D., Ibarra, G. H., Srivastava, A., de Castro, J. P. W., DeIuliis, G., Ahangari, F., Woolard, T., et al. (2018) · Nature Medicine · doi:10.1038/nm.4447 · Cited by 356
Self-citationOldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341
Telomere dysfunction causes alveolar stem cell failure
Alder, J. K., Barkauskas, C. E., Limjunyawong, N., Stanley, S. E., Kembou, F., Tuder, R. M., Hogan, B. L. M., Mitzner, W., & Armanios, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504780112 · Cited by 339
Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., Glaspole, I., Glassberg, M. K., Kardatzke, D. R., Daigl, M., Kirchgaessler, K.-U., Lancaster, L. H., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30326-5 · Cited by 335
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Self-citationAllen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., Guillen-Guio, B., Ma, S.-F., Okamoto, T., John, A. E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30387-9 · Cited by 297
Self-citationLung transplantation for idiopathic pulmonary fibrosis
George, P. M., Patterson, C. M., Reed, A. K., & Thillai, M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30502-2 · Cited by 297
van Moorsel, C. H. M., van Oosterhout, M. F. M., Barlo, N. P., de Jong, P. A., van der Vis, J. J., Ruven, H. J. T., van Es, H. W., van den Bosch, J. M. M., & Grutters, J. C. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0953oc · Cited by 294
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
Kheirollahi, V., Wasnick, R. M., Biasin, V., Vazquez-Armendariz, A. I., Chu, X., Moiseenko, A., Weiss, A., Wilhelm, J., Zhang, J.-S., Kwapiszewska, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10839-0 · Cited by 293
Liang, J., Zhang, Y., Xie, T., Liu, N., Chen, H., Geng, Y., Kurkciyan, A., Mena, J. M., Stripp, B. R., Jiang, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4192 · Cited by 287
Chambers, D. C., Enever, D., Ilic, N., Sparks, L., Whitelaw, K., Ayres, J., Yerkovich, S. T., Khalil, D., Atkinson, K. M., & Hopkins, P. M. A. (2014) · Respirology · doi:10.1111/resp.12343 · Cited by 278
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267
Mulugeta, S., Nguyen, V., Russo, S. J., Muniswamy, M., & Beers, M. F. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0009oc · Cited by 257
Galli, J. A., Pandya, A., Vega‐Olivo, M., Dass, C., Zhao, H., & Criner, G. J. (2017) · Respirology · doi:10.1111/resp.13024 · Cited by 257
Tzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255
Self-citationExpression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis
Nureki, S.-I., Tomer, Y., Venosa, A., Katzen, J., Russo, S. J., Jamil, S., Barrett, M., Nguyen, V., Kopp, M., Mulugeta, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99287 · Cited by 250
Glassberg, M. K., Minkiewicz, J., Toonkel, R. L., Simonet, E. S., Rubio, G. A., DiFede, D., Shafazand, S., Khan, A., Pujol, M. V., LaRussa, V. F., et al. (2017) · Chest · doi:10.1016/j.chest.2016.10.061 · Cited by 249
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2088oc · Cited by 242
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07858-8 · Cited by 224
Self-citationHost–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Molyneaux, P. L., Willis-Owen, S. A. G., Cox, M. J., James, P., Cowman, S., Loebinger, M., Blanchard, A., Edwards, L. M., Stock, C., Daccord, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1408oc · Cited by 217
Self-citationA Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis
Zhang, Y., Noth, I., Garcia, J. G. N., & Kaminski, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1013504 · Cited by 214
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207429 · Cited by 206
Self-citationRare Variants in RTEL1 Are Associated with Familial Interstitial Pneumonia
Cogan, J. D., Kropski, J. A., Zhao, M., Mitchell, D. B., Rives, L., Markin, C., Garnett, E. T., Montgomery, K. H., Mason, W. R., McKean, D. F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1510oc · Cited by 196
Self-citationDressen, A., Abbas, A. R., Cabanski, C., Reeder, J., Ramalingam, T. R., Neighbors, M., Bhangale, T. R., Brauer, M. J., Hunkapiller, J., Reeder, J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30135-8 · Cited by 196
Self-citationDrug Treatment of Idiopathic Pulmonary Fibrosis
Canestaro, W. J., Forrester, S. H., Raghu, G., Ho, L., & Devine, B. E. (2016) · Chest · doi:10.1016/j.chest.2015.11.013 · Cited by 186
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Borie, R., Tabèze, L., Thabut, G., Nunes, H., Cottin, V., Marchand-Adam, S., Prevot, G., Tazi, A., Cadranel, J., Mal, H., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2015 · Cited by 184
Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis
Alder, J. K., Stanley, S. E., Wagner, C. L., Hamilton, M., Hanumanthu, V. S., & Armanios, M. (2015) · Chest · doi:10.1378/chest.14-1947 · Cited by 181
Katzenstein, A.-L. A., Mukhopadhyay, S., & Myers, J. L. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.05.009 · Cited by 177
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Tzouvelekis, A., Gomatou, G., Bouros, E., Trigidou, R., Tzilas, V., & Bouros, D. (2019) · Chest · doi:10.1016/j.chest.2019.04.114 · Cited by 176
Self-citationHerazo-Maya, J. D., Sun, J., Molyneaux, P. L., Li, Q., Villalba, J. A., Tzouvelekis, A., Lynn, H., Juan-Guardela, B. M., Risquez, C., Osorio, J. C., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30349-1 · Cited by 175
Self-citationNewton, C. A., Oldham, J. M., Ley, B., Anand, V., Adegunsoye, A., Liu, G., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01641-2018 · Cited by 174
Chen, C., Peng, Y., Wang, Z., Fish, P., Kaar, J., Koepsel, R., Russell, A., Lareu, R., & Raghunath, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00387.x · Cited by 168
Hill, C. N., Jones, M. G., Davies, D. E., & Wang, Y. (2019) · Journal of Lung Health and Diseases · doi:10.29245/2689-999x/2019/2.1149 · Cited by 167
Self-citationWilkinson, D. C., Alva-Ornelas, J. A., Sucre, J. M. S., Vijayaraj, P., Durra, A., Richardson, W., Jonas, S. J., Paul, M. K., Karumbayaram, S., Dunn, B., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0192 · Cited by 165
Jones, M. G., Andriotis, O. G., Roberts, J. J., Lunn, K., Tear, V. J., Cao, L., Ask, K., Smart, D. E., Bonfanti, A., Johnson, P., et al. (2018) · eLife · doi:10.7554/elife.36354 · Cited by 162
Self-citationA Novel Dyskerin (DKC1) Mutation Is Associated With Familial Interstitial Pneumonia
Kropski, J. A., Mitchell, D. B., Markin, C. R., Polosukhin, V. V., Choi, L., Johnson, J. E., Lawson, W. E., Phillips, J. A., Cogan, J. D., Blackwell, T. S., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2224 · Cited by 155
Self-citationA randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
Lukey, P. T., Harrison, S. A., Yang, S., Man, Y., Holman, B. F., Rashidnasab, A., Azzopardi, G., Grayer, M., Simpson, J. K., Bareille, P. J., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01992-2018 · Cited by 154
Self-citationKim, S. Y., Diggans, J., Pankratz, D., Huang, J., Pagan, M., Sindy, N., Tom, E., Anderson, J. D., Choi, Y., Lynch, D. A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00140-x · Cited by 148
Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis. Potential for Clinical Testing
Toonkel, R. L., Hare, J. M., Matthay, M. A., & Glassberg, M. K. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1204pp · Cited by 147
Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study
Verleden, S. E., Tanabe, N., McDonough, J. E., Vasilescu, D. M., Xu, F., Wuyts, W. A., Piloni, D., Sadeleer, L. D., Willems, S., Mai, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30356-x · Cited by 136
Homma, S. A., Azuma, A., Taniguchi, H., Ogura, T., Mochiduki, Y., Sugiyama, Y., Nakata, K., Yoshimura, K., Takeuchi, M., & Kudoh, S. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02132.x · Cited by 131
Moore, C. M., Blumhagen, R. Z., Yang, I. V., Walts, A. D., Powers, J., Walker, T., Bishop, M. M., Russell, P. H., Vestal, B. E., Cardwell, J., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1891oc · Cited by 123
Self-citationDifferential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Wuyts, W. A., Cavazza, A., Rossi, G., Bonella, F., Sverzellati, N., & Spagnolo, P. (2014) · European Respiratory Review · doi:10.1183/09059180.00004914 · Cited by 122
Self-citationThe Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review
Diamantopoulos, A., Wright, E., Vlahopoulou, K., Cornic, L., Schoof, N., & Maher, T. M. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0631-8 · Cited by 122
Self-citationThree-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis
Jones, M. G., Fabre, A., Schneider, P., Cinetto, F., Sgalla, G., Mavrogordato, M., Jogai, S., Alzetani, A., Marshall, B. G., O’Reilly, K. M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86375 · Cited by 105
Self-citationKreuter, M., Bonella, F., Wijsenbeek, M. S., Maher, T. M., & Spagnolo, P. (2015) · BioMed Research International · doi:10.1155/2015/329481 · Cited by 101
Self-citationMinimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Kumamoto, M., Nishiwaki, T., Matsuo, N., Kimura, H., & Matsushima, K. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128508 · Cited by 95
Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
Spagnolo, P., Maher, T. M., & Richeldi, L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.04.005 · Cited by 94
Self-citationSurfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred
Ono, S., Tanaka, T., Ishida, M., Kinoshita, A., Fukuoka, J., Takaki, M., Sakamoto, N., Ishimatsu, Y., KOHNO, S., Hayashi, T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00143610 · Cited by 92
Integrierte Analyse von Patienten-Genen und respiratorischem Mikrobiom
(2017) · Pneumologie · doi:10.1055/s-0043-104350 · Cited by 92
Chen, R., Zhang, K., Chen, H., Zhao, X., Wang, J., Li, L., Cong, Y., Ju, Z., Xu, D., Williams, B. R. G., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681619 · Cited by 89
Coghlan, M. A., Shifren, A., Huang, H. J., Russell, T. D., Mitra, R. D., Zhang, Q., Wegner, D., Cole, F. S., & Hamvas, A. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000057 · Cited by 89
Chilosi, M., Caliò, A., Rossi, A., Gilioli, E., Pedica, F., Montagna, L., Pedron, S., Confalonieri, M., Doglioni, C., Ziesche, R., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.147 · Cited by 85
Mahan, V. L. (2014) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2014.521175 · Cited by 84
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Self-citationThe Management of Patients With Idiopathic Pulmonary Fibrosis
Spagnolo, P., Τzouvelekis, Α., & Bonella, F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00148 · Cited by 81
Self-citationMesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
Tzouvelekis, A., Toonkel, R. L., Karampitsakos, Τ., Medapalli, K., Ninou, I., Aidinis, V., Bouros, D. E., & Glassberg, M. K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00142 · Cited by 81
Self-citationZhu, L., Wang, L., Luo, X., Zhang, Y., Ding, Q., Jiang, X., Wang, X., Pan, Y., & Chen, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388009 · Cited by 79
Gazdhar, A., Susuri, N., Hostettler, K., Gugger, M., Knudsen, L., Roth, M., Ochs, M., & Geiser, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065453 · Cited by 78
Chen, G., Ribeiro, C. M. P., Sun, L. V., Okuda, K., Kato, T., Gilmore, R. C., Martino, M. B., Dang, H., Abzhanova, A., Lin, J. M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1972oc · Cited by 77
Maher, T. M., Simpson, J. K., Porter, J. C., Wilson, F. J., Chan, R. H., Eames, R., Cui, Y., Siederer, S. K., Parry, S., Kenny, J. D., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01339-7 · Cited by 73
Self-citationClinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis
Bando, M., Yamauchi, H., Ogura, T., Taniguchi, H., Watanabe, K., Azuma, A., Homma, S. A., & Sugiyama, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5272 · Cited by 72
Sakamoto, S., Muramatsu, Y., Satoh, K., Ishida, F., Kikuchi, N., Sano, G., Sugino, K., Isobe, K., Takai, Y., & Homma, S. A. (2015) · Respirology · doi:10.1111/resp.12477 · Cited by 71
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
Sakamoto, S., Kataoka, K., Kondoh, Y., Kato, M., Okamoto, M., Mukae, H., Bando, M., Suda, T., Yatera, K., Tanino, Y., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00348-2020 · Cited by 67
Idiopathic Pulmonary Fibrosis is a Genetic Disease Involving Mucus and the Peripheral Airways
Schwartz, D. A. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201802-144aw · Cited by 62
Bellaye, P., & Kolb, M. R. J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0412-6 · Cited by 61
Ntolios, P., Manoloudi, E., Τzouvelekis, Α., Bouros, E., Steiropoulos, P., Anevlavis, S., Bouros, D. E., & Froudarakis, Μ. E. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12777 · Cited by 59
Novel Clinical Trial Designs to Improve the Efficiency of Research
Sessler, D. I., & Myles, P. S. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002989 · Cited by 58
Multipotent mesenchymal stem cells in lung fibrosis
Hostettler, K., Gazdhar, A., Khan, P., Savic, S., Tamò, L., Lardinois, D., Roth, M., Tamm, M., & Geiser, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181946 · Cited by 57
Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
Barczyk, M., Schmidt, M., & Mattoli, S. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9587-7 · Cited by 53
Myllärniemi, M., Vuorinen, K., Pulkkinen, V., Kankaanranta, H., Aine, T., Salmenkivi, K., Keski‐Oja, J., Koli, K., & Kinnula, V. (2007) · The Journal of Pathology · doi:10.1002/path.2300 · Cited by 49
Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families
Kropski, J. A., Reiss, S., Markin, C. R., Brown, K. K., Schwartz, D. A., Schwarz, M. I., Loyd, J. E., Phillips, J. A., Blackwell, T. S., & Cogan, J. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0635le · Cited by 48
Self-citationProminin-1/CD133+ Lung Epithelial Progenitors Protect from Bleomycin-induced Pulmonary Fibrosis
Germano, D., Błyszczuk, P., Valaperti, A., Kania, G., Dirnhofer, S., Landmesser, U., Lüscher, T. F., Hunziker, L., Zulewski, H., & Eriksson, U. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1390oc · Cited by 43
Harada, T., Nabeshima, K., Hamasaki, M., Uesugi, N., Watanabe, K., & Iwasaki, H. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02469.x · Cited by 43
Khoo, J. K., Montgomery, A. B., Otto, K. L., Surber, M., Faggian, J., Lickliter, J. D., & Glaspole, I. (2020) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2018.1507 · Cited by 40
The role of histology in idiopathic pulmonary fibrosis: An update
Cavazza, A., Rossi, G., Carbonelli, C. M., Spaggiari, L., Paci, M., & Roggeri, A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.03.013 · Cited by 39
Self-citationThe topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
Usmani, O. S., Biddiscombe, M. F., Yang, S., Meah, S., Oballa, E., Simpson, J. K., Fahy, W. A., Marshall, R. P., Lukey, P. T., & Maher, T. M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0732-0 · Cited by 33
Self-citationHirani, N., Nicol, L. M., MacKinnon, A. C., Ford, P., Schambye, H. T., Pedersen, Nilsson, U., Leffler, H., Thomas, T., Knott, O., et al. (2016) · QJM · doi:10.1093/qjmed/hcw127.003 · Cited by 21
Self-citationSenescence of Alveolar Stem Cells Drives Progressive Pulmonary FibrosisPreprint
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G., Soukiasian, H. J., David, G., WEIGT, S. S., Belperio, J. A., et al. (2019) · SSRN Electronic Journal · doi:10.1101/820175 · Cited by 21
An Overview of Drug Development in the United States and Current Challenges
Moore, S. W. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000102285.48482.c9 · Cited by 12
Biopsy in idiopathic pulmonary fibrosis: back to the future
Rossi, G., & Spagnolo, P. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1351302 · Cited by 3
Self-citation
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01256 · Cited by 61
Lv, J., Gao, H., Ma, J., Liu, J., Tian, Y., Yang, C., Li, M., Zhao, Y., Li, Z., Zhang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230266 · Cited by 48
Zhong, W., Chen, W., Liu, Y., Zhang, J., Lu, Y., Wan, X., Qiao, Y., Huang, H., Zeng, Z., Li, W., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200406rr · Cited by 23
The Role of Osteopontin in Respiratory Health and Disease
Barkas, G. I., & Kotsiou, O. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081259 · Cited by 16
Metadata
- Authors
- Spagnolo, P., Kropski, J. A., Jones, M. G., Lee, J. S., Rossi, G., Karampitsakos, T., Maher, T. M., Tzouvelekis, A., & Ryerson, C. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 222
- Pages
- 107798
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W3116084499
- Cited by
- 636
- References
- 134
- FWCI
- 28.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.